ArticleScientific reports2025
A prognostic model integrating radiomics and deep learning based on CT for survival prediction in laryngeal squamous cell carcinoma.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Laryngeal Anatomy and Morphometry: Foundations for Interdisciplinary Collaboration and Personalized Management of Laryngeal Pathology.Diagnostics (Basel, Switzerland) · 2026Review
- Radiomics in laryngeal squamous cell carcinoma: state of the art.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2026Review
- Artificial intelligence in multidisciplinary tumor boards enhancing decision making and clinical outcomes in oncology.iScience · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Accurate prognostic prediction is crucial for patients with laryngeal squamous cell carcinoma (LSCC) to guide personalized treatment strategies. This study aimed to develop a comprehensive prognostic model leveraging clinical factors alongside radiomics and deep learning (DL) based on CT imaging to predict recurrence-free survival (RFS) in LSCC patients. We retrospectively enrolled 349 patients with LSCC from Center 1 (training set: n = 189; internal testing set: n = 82) and Center 2 (external testing set: n = 78). A combined model was developed using Cox regression analysis to predict RFS in LSCC patients by integrating independent clinical risk factors, radiomics score (RS), and deep learning score (DLS). Meanwhile, separate clinical, radiomics, and DL models were also constructed for comparison. Furthermore, the combined model was represented visually through a nomogram to provide personalized estimation of RFS, with its risk stratification capability evaluated using Kaplan-Meier analysis. The combined model achieved a higher C-index than did the clinical model, radiomics model, and DL model in the internal testing (0.810 vs. 0.634, 0.679, and 0.727, respectively) and external testing sets (0.742 vs. 0.602, 0.617, and 0.729, respectively). Additionally, following risk stratification via nomogram, patients in the low-risk group showed significantly higher survival probabilities compared to those in the high-risk group in the internal testing set [hazard ratio (HR) = 0.157, 95% confidence interval (CI): 0.063-0.392, p < 0.001] and external testing set (HR = 0.312, 95% CI: 0.137-0.711, p = 0.003). The proposed combined model demonstrated a reliable and accurate ability to predict RFS in patients with LSCC, potentially assisting in risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.